Persistent URL of this record https://hdl.handle.net/1887/97194
In Collections
This item can be found in the following collections:
Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs
- All authors
- Dawes, P.; Dimic, A.; Genovese, M.C.; Heijde, D. van der; Jenkins, M.; O'Brien, C.; Oemar, B.; Vencovsky, J.; Weinblatt, M.
- Date
- 2013-10-31
- Journal
- Arthritis and Rheumatism
- Volume
- 65
- Pages
- S198 - S199